Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.

doi:10.1161/CIRCRESAHA.123.322757

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.

Circulation research - 19 Jan 2024

Julla Jean-Baptiste, Girard Diane, Diedisheim Marc, Saulnier Pierre-Jean, Tran Vuong Bao, Blériot Camille, Carcarino Elena, De Keizer Joe, Orliaguet Lucie, Nemazanyy Ivan, Potier Charline, Khider Kennan, Tonui Dorothy Chepngenoh, Ejlalmanesh Tina, Ballaire Raphaelle, Mambu Mambueni Hendrick, Germain Stéphane, Gaborit Bénédicte, Vidal-Trécan Tiphaine, Riveline Jean-Pierre, Garchon Henri-Jean, Fenaille François, Lemoine Sophie, Carlier Aurélie, Castelli Florence, Potier Louis, Masson David, Roussel Ronan, Vandiedonck Claire, Hadjadj Samy, Alzaid Fawaz, Gautier Jean-François, Venteclef Nicolas

Abstract excerpt

BACKGROUND: Diabetes is a major risk factor for atherosclerotic cardiovascular diseases with a 2-fold higher risk of cardiovascular events in people with diabetes compared with those without. Circulating monocytes are inflammatory effector cells involved in both type 2 diabetes (T2D) and atherogenesis. METHODS: We investigated the relationship between circulating monocytes and cardiovascular risk progression in...

Read the complete abstract on PubMed